Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FYCKL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,101
Award facts
- Contract value 100% obligated
- $6,100.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,100.64 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen medication on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under DLA's broader pharmaceutical procurement framework. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a critical pharmaceutical distributor for federal medical supply chains.
This delivery order is issued under AmerisourceBergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which extends through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs, including support for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's track record of competitively awarded contracts with DLA demonstrates its established capability to fulfill federal medical supply requirements across multiple therapeutic domains, positioning the company as a significant vendor within the defense pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB26FYCKL?
SPE2DB26FYCKL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DB26FYCKL worth?
The government has obligated $6,101 on SPE2DB26FYCKL.
Is contract SPE2DB26FYCKL an order under another contract?
Yes. SPE2DB26FYCKL is a delivery order under SPE2DB20D3505, an indefinite delivery contract.
Was contract SPE2DB26FYCKL competed?
The extent of competition for SPE2DB26FYCKL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award